Parataxis Holdings LLC has agreed to invest nearly $18.3 million (KRW 25 billion) in South Korea’s Bridge Biotherapeutics, gaining a controlling stake and rebranding the company as Parataxis Korea. Once finalized, the deal will establish the first Bitcoin-native treasury platform in the South Korean public markets, leveraging the digital asset expertise of Parataxis Capital. Leadership […]
Source link
US Senators Unveil Draft Bill to Overhaul Crypto Regulation Framework
A sweeping Senate draft bill sets the stage for overhauling U.S. crypto regulation, proposing clear classifications, limited SEC oversight, and...
